The mainstream media doesn't regulate medicine and this is bogus.
"Medicine that doesn't treat or prevent COVID-19
Early in the COVID-19 pandemic, no treatments for COVID-19 existed. Researchers tested medicines based in the idea that the drugs could treat or prevent COVID-19.
As research has grown, health agencies such as the FDA have authorized or approved the medicines that work and are safe. Researchers also have found out which medicines don't work to treat or prevent COVID-19.
Some medicines stop working because the virus that causes COVID-19 changes.
Examples are bebtelovimab and the combination tixagevimab-cilgavimab (Evusheld). These medicines were based on proteins the body naturally creates to block the COVID-19 virus. But when the virus changed over time, the proteins in the medicine no longer matched up to the virus and stopped working.
Another example is an HIV medicine. It's a combination of two drugs, lopinavir and ritonavir, tested in clinical trials to treat COVID-19. But the trials failed to show a benefit, and the combination is no longer an option to treat COVID-19.
Other examples are ivermectin, hydroxychloroquine or chloroquine.
Claims that ivermectin, hydroxychloroquine or chloroquine can treat COVID-19 are false. These medicines are still useful for treating other illness. But only medicines approved or authorized by the FDA to treat COVID-19 are useful for that illness."
Medicine can help people who are at risk of, diagnosed with, or have symptoms of COVID-19.
www.mayoclinic.org
"Conclusions and relevance
Our meta-analysis of 10 RCTs investigating the safety and efficacy of HCQ as pre-exposure prophylaxis in HCWs found that compared with placebo, HCQ does not significantly reduce the risk of confirmed or clinically suspected SARS-CoV-2 infection, while
HCQ significantly increases adverse events."
We studied the safety and efficacy of hydroxychloroquine (HCQ) as pre-exposure prophylaxis for COVID-19 in healthcare workers (HCWs), using a meta-analysis of randomised controlled trials (RCTs).PubMed and EMBASE databases were searched to identify randomised ...
www.ncbi.nlm.nih.gov
- "Hydroxychloroquine was prescribed in hospitalised patients with Covid-19 despite of the low-level evidence.•Subsequently, HCQ use was associated with an 11% increase in the mortality rate in a meta-analysis of randomized trials.
- •
The number of hydroxychloroquine related deaths in hospitalised patients is estimated at 16,990 in six countries.
- •
These findings illustrate the hazard of drug repurposing with low-level evidence for the management of future pandemics."